SRSF2 and acute myeloid leukemia: Another PDX model designated as PDX-AML-4 was recently generated from patient P6730: 65-year-old women with AML M2 marked with mutations in ASXL1, BCOR, NRAS, RUNX1, SRSF2, and STAG2 (see Table 1 in red).